Skip to main content
. 2016 Mar 25;54(5):448–459. doi: 10.2486/indhealth.2015-0202

Table 3. Comparison of biomarkers and pulmonary function tests between the toner–handling group and the non–toner handling group from 2004 to 2008.

Parameters (Unit) Groups n 2004 2005 2006 2007 2008 F valuea p value
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
WBC
(/μl)
Toner–handling group 32 7056.3 (1447.1) 7337.5 (2116.1) 6696.9 (1711.3) 6159.4 (1267.2) 6987.5 (1838.4) 0.270 0.847
Non–toner–handling group 45 6571.1 (1931.6) 6500.0 (2167.2) 6293.3 (1829.4) 6171.1 (1655.8) 6386.7 (1758.0)
Total 77 6772.7 (1752.8) 6848.1 (2172.2) 6461.0 (1781.1) 6166.2 (1497.4) 6636.4 (1804.7)
KL–6
(U/ml)
Toner–handling group 32 235.2 (84.4) 247.0 (79.5) 244.7 (82.1) 226.5 (83.5) 222.8 (82.2) 0.411 0.757
Non–toner–handling group 45 204.6 (76.6) 209.4 (76.0) 208.6 (66.7) 199.4 (75.2) 202.9 (85.1)
Total 77 217.4 (80.8) 225.0 (79.2) 223.6 (75.1) 210.7 (79.4) 211.1 (84.0)
SP–D
(ng/ml)
Toner–handling group 32 51.2 (24.4) 44.7 (22.2) 39.1 (18.5) 41.1 (22.2) 46.9 (22.7) 1.231 0.289
Non–toner–handling group 45 58.1 (30.1) 53.6 (27.3) 49.6 (28.4) 49.6 (26.1) 52.6 (28.0)
Total 77 55.2 (27.9) 49.9 (25.5) 45.2 (25.2) 46.1 (24.7) 50.2 (25.9)
8–OHdG
(mg/dl)
Toner–handling group 27 4.3 (1.7) 4.8 (2.3) 4.3 (1.7) 4.2 (1.7) 3.9 (1.4) 0.145 0.941
Non–toner–handling group 42 5.0 (1.9) 5.0 (1.6) 4.9 (1.7) 4.5 (1.6) 4.5 (1.3)
Total 69 4.7 (1.9) 4.9 (1.9) 4.7 (1.7) 4.4 (1.6) 4.2 (1.4)
CRPb
(mg/dl)
Toner–handling group 32 0.22 (0.26) 0.53 (1.08) 0.17 (0.13) 0.12 (0.20) 0.17 (0.32)
Non–toner–handling group 45 0.21 (0.38) 0.18 (0.28) 0.22 (0.68) 0.07 (0.08) 0.17 (0.52)
Total 77 0.21 (0.34) 0.33 (0.74) 0.20 (0.53) 0.09 (0.14) 0.17 (0.44)
%VC
(%)
U values / p valuec 634.5 / 0.274 601.0 / 0.110 582.5 / 0.064 577.5 / 0.139 584.5 / 0.160
Toner–handling group 31 111.0 (14.1) 107.9 (15.2) 109.0 (13.3) 108.4 (14.6) 113.2 (13.9) 3.534 0.020*
Non–toner–handling group 39 112.7 (11.3) 111.6 (14.8) 113.4 (12.4) 113.8 (12.2) 118.3 (15.4)
Total 70 112.0 (12.6) 109.9 (15.0) 111.4 (12.9) 111.4 (13.5) 116.1 (14.9)
FEV1.0%
(%)
Toner–handling group 31 82.1 (5.8) 81.1 (9.1) 82.8 (5.5) 83.0 (6.0) 82.0 (5.2) 1.588 0.201
Non–toner–handling group 38 84.5 (6.0) 85.4 (6.7) 83.9 (5.7) 82.4 (6.8) 81.1 (7.3)
Total 69 83.4 (6.0) 83.5 (8.1) 83.4 (5.6) 82.7 (6.4) 81.5 (6.4)

SD: standard deviation, WBC: white ball cell, KL–6: Sialylated carbohydrate antigen KL–6, SP–D: surfactant protein D, 8–OHdG: 8–hydroxy–2’–deoxyguanosine, CRP: C–reactive protein, %VC: vital capacity as percent of predicted, FEV1.0%: forced expiratory volume percentile in one second.

a In mixed model repeated ANOVA, the sphericity assumption was violated; to account for this violation, degrees of freedom were Greenhouse–Geisser adjusted.

b The serum level of CRP was measured using turbidimetric immunoassay (TIA) from 2004 to 2006 and latex immunoagglutination assay (LA) from 2007 to 2008. Limits of detection (LOD) for CRP were 0.1 mg/dl in using TIA and 0.01 mg/dl in using LA.

c Mann–Whitney U test was performed on the serum levels of CRP between the toner–handling group and non–toner–handling groups in each year of the survey.

* p<0.05. The levels of %VC in 2008 were significantly more than the level of 2006 to 2007 in the toner–handling group, and the levels in 2008 were significantly more than the levels from 2004 to 2007 in the non–toner–handling group with Bonferroni multiple comparison procedure.